Brokerages Set Haleon plc (NYSE:HLN) PT at $12.33

Haleon plc (NYSE:HLN - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eleven analysts that are currently covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $12.33.

HLN has been the subject of several research reports. Wall Street Zen upgraded Haleon from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target on the stock in a research note on Tuesday, May 27th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Haleon in a research note on Monday, March 3rd. Finally, HSBC reiterated a "hold" rating on shares of Haleon in a report on Wednesday, March 5th.

Hedge Funds Weigh In On Haleon

Several large investors have recently modified their holdings of the business. Bartlett & CO. Wealth Management LLC boosted its stake in Haleon by 135.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock worth $27,000 after buying an additional 1,491 shares during the period. Sierra Ocean LLC acquired a new stake in Haleon in the 4th quarter valued at approximately $26,000. Banque Transatlantique SA acquired a new stake in Haleon in the 1st quarter valued at approximately $27,000. Opal Wealth Advisors LLC purchased a new stake in Haleon in the first quarter valued at approximately $29,000. Finally, Ransom Advisory Ltd acquired a new position in Haleon during the first quarter worth $31,000. Institutional investors and hedge funds own 6.67% of the company's stock.

Haleon Price Performance

HLN stock traded down $0.15 during trading on Tuesday, hitting $10.87. The stock had a trading volume of 10,805,488 shares, compared to its average volume of 8,907,387. Haleon has a twelve month low of $8.25 and a twelve month high of $11.42. The company's 50-day moving average price is $10.58 and its two-hundred day moving average price is $10.06. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The stock has a market capitalization of $48.92 billion, a P/E ratio of 31.96, a PEG ratio of 2.82 and a beta of 0.31.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.